If you currently have an active log in on the old SSS Australia website, you already have an account set up and ready to go on our new website.
All you need to do is Click Here and input the email address you are currently using to log in to the SSS Australia website.
You will receive a link via email (check your spam/junk folder) and use it to set a new password.
Simply follow the links below to sign up!
If you are an existing customer, you just need web access: Apply Now
If you want to become a customer, click here to apply.
Your independent, local healthcare industry supplier, for more than 45 years
The World Health Organisation has released its recommendations for the viral composition of influenza vaccines for the upcoming 2024 influenza season.To coincide, early bird orders for 2024 influenza vaccines are now available.
The WHO recommends that trivalent vaccines for use in the 2024 southern hemisphere influenza season contain the following:
Egg-based vaccines
Cell culture- or recombinant-based vaccines
For quadrivalent egg- or cell culture-based or recombinant vaccines for use in 2024 southern hemisphere influenza season, the WHO recommends inclusion of the following B/Yamagata lineage component:
a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.